Click to Share

Filter News
Show All Results
News By Country
News By Tag
Dyskinesia Remove

November 2019

Public Company News

Business Press Releases

Dyskinesia Press Releases

Exclusive News
Topics Locations Industries Dates

By Neurolixis, Inc.
The US Food and Drug Administration (FDA) gave a positive response to Neurolixis' Investigational New Drug (IND) application for NLX-112.
By Neurolixis
Neurolixis launched a collaboration with the GALA® laboratory in Castres, France. GALA® is a platform of the Rapsodee/IMT Mines Albi research facility specialized in developing novel drug formulations.

Page updated every 10 minutes

Like PRLog?
Click to Share